InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+3.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Henrik Krook, Executive. Officer active across 1 company, notably Egetis Therapeutics AB (publ). Cumulatively, 2 reports have been logged. Activity tracked since 26 November 2025. The latest transaction was disclosed on 11 May 2026 (Purchase). Regulator: FIN-FSA. All data is free.
Declarations2 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
264,880 shares0AktieFI:A003Y615-1
Ideal exit: 5 Feb 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEgetis Therapeutics AB (publ)
25,000 shares@ €0.35720.0004% mcap100.0% of flowAktieFI:A003U240-1
Ideal exit: 23 Aug 2026 (T+270)
2 of 2 declarations
About Henrik Krook
Henrik Krook is a member of the administration of Egetis Therapeutics AB (publ). He is involved in strategic decision-making and oversight of the company's operations.
